Sarepta Therapeutics (NASDAQ: SRPT) files Form 13F showing 1 entry

Rhea-AI Filing Summary

Sarepta Therapeutics, Inc. submitted a Form 13F holdings report signed by Ryan Wong on 05-13-2026. The report lists 1 Form 13F information table entry with a total reported value of $0 and shows 0 other included managers. The filing attests that the signatory is authorized and that the information is true and complete.

Key Figures

Form 13F Information Table Entry Total: 1 Form 13F Information Table Value Total: $0 Number of Other Included Managers: 0 +1 more

4 metrics

Form 13F Information Table Entry Total 1 summary page

Form 13F Information Table Value Total $0 round to nearest dollar

Number of Other Included Managers 0 summary page

Signature Date 05-13-2026 signed by Ryan Wong in Las Vegas, NV

Key Terms

Form 13F, Form 13F Information Table, Other Included Managers

3 terms

Form 13F regulatory

"Report Type X | 13F HOLDINGS REPORT"

A Form 13F is a quarterly filing that large investment managers must submit to disclose their holdings in publicly traded stocks and certain other securities. It acts like a peek into the portfolios of big investors, helping other market participants see what large players are buying or selling and offering clues about investment trends, crowded trades, and potential market impact.

Form 13F Information Table regulatory

"Form 13F Information Table Entry Total: | 1"

Other Included Managers regulatory

"Number of Other Included Managers: | 0"

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE

OMB APPROVAL

OMB Number:			3235-0006
Estimated average burden
hours per response:			23.8

Report for the Calendar Year or Quarter Ended: 03-31-2026

Check here if Amendment		Amendment Number:
This Amendment (Check only one.):		is a restatement.
		adds new holdings entries.

Institutional Investment Manager Filing this Report:
Name:	Sarepta Therapeutics, Inc.
Address:	215 First Street
	Suite 415
	Cambridge, MA 02142
Form 13F File Number:	028-26297
CRD Number (if applicable):
SEC File Number (if applicable):

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager:
Name:		Ryan Wong
Title:		Executive Vice President, Chief Financial Officer
Phone:		617-274-4000
Signature, Place, and Date of Signing:
/s/ Ryan Wong			Las Vegas, NV	05-13-2026
[Signature]			[City, State]	[Date]

Report Type (Check only one.):
X	13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.)
	13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).)
	13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

Form 13F Summary Page
	Report Summary:
	Number of Other Included Managers:		0
	Form 13F Information Table Entry Total:		1
	Form 13F Information Table Value Total:		0
			(round to nearest dollar)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

NONE

FAQ

What does Sarepta Therapeutics' Form 13F filing (SRPT) show?

It reports one 13F entry with a total value of $0. The filing lists 1 information-table entry, a Form 13F holdings report type, and indicates 0 other included managers.

Who signed the 13F report for Sarepta Therapeutics and when?

Ryan Wong, Executive Vice President and CFO, signed the report. The signature block shows the filing was signed in Las Vegas, NV on 05-13-2026 and includes a company phone number.

Does the Form 13F filing disclose detailed holdings for SRPT?

The summary indicates one table entry but a total value of $0. The report type is a 13F holdings report; the filing does not indicate positive dollar value in the summary fields provided here.

Are other institutional managers included in Sarepta's 13F filing?

No — the filing lists zero other included managers. The report explicitly states NONE for the list of other included managers and reports 0 in that summary field.